Semler Scientific, an emerging medical risk-assessment company whose mission is to produce products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services, has appointed Dr Wayne Pan to the company's board of directors.
Dr Pan will also serve as a member of the board's audit committee and the nominating committee. Dr Pan is currently serving as chief medical officer at Thrasys. He has over 20 years of broad healthcare industry experience in clinical medicine, managed care and health information technology.
"Wayne's experience in building and leading teams in healthcare technology and managed care, brings great value to Semler and to our board of director as we build our sales and marketing efforts and develop new products," said Dr Doug Murphy-Chutorian, chief executive officer of Semler.
Since August 2012, Dr. Pan has been chief medical officer at Thrasys, Inc., a global healthcare technology company that provides a cloud-based platform upon which healthcare delivery systems and provider organizations can build high quality, person-centered accountable care communities.
Dr Wayne Pan, Semler Scientific, US